The Intervention on Aging System; a Classification Model the Requirement for Five Novel Categories
Raymond D Palmer*
Department of Health Sciences, Curtin University, Australia
Submission: October 02, 2021; Published: October 22,2021
*Corresponding author: Raymond D Palmer, Helium-3 Biotech, School of Medicine, Faculty of Health Sciences, Curtin University, Australia
How to cite this article: Raymond D P. The Intervention on Aging System; a Classification Model the Requirement for Five Novel Categories. OAJ 002 Gerontol & Geriatric Med. 2021; 6(2): 555685. DOI: 10.19080/OAJGGM.2021.06.555685
Summary
Aging is widely considered an immovable fact of life. Cultural conditioning ensures that conversations of extreme human life spans are considered primarily nonsense and to be only applicable to the world of science fiction movies. On the other hand, longevity therapies such as stem cell replacement, fasting, gene therapies, fasting mimetics such as metformin and rapamycin, regulation and tissue reprogramming with OSK transcription factors, blood dilution, metabolic pathway engineering, reversal of epigenetic drift, heterochronic parabiosis, coenzyme replacement technologies (nicotinamide adenine dinucleotide) and a plethora of other established science are showing great potential at slowing down the rate at which tissues enter dysfunction.
Recent discoveries have shed light on major mysteries of the aging process. Longevity-based discoveries are not only landing quickly, but therapies to prevent or reverse those drivers of aging are also being devised regularly and this is opening-up an entirely new industry, the longevity industry. This presents the requirement for a new classification system where subjects can be divided into specific groups based on their potential for mortality. This system also enables the public to target which class of this classification system they wish to be on. Moving the population on the classification system to become more disease resistant holds great benefit for society and governments as a whole.
Keywords : Aging; Gerontology; Longevity industry; Health industry; Experimental
Discussion
The longevity industry is vastly different than the health industry. Health foods and health products may deliver health benefits, but only if you are deficient in a vitamin or mineral, but no health product has been shown to profoundly extend lifespan (if at all) [1]. The study by Khan et al. 2019 conducted nine systematic reviews and four randomized control trials were chosen that embodied a total of 277 trials, 24 interventions with a total of 992,129 participants. This data from John Hopkins Medicine supports the idea that an avid user of health products will still age and experience biological decay at their natural rate of aging. John Hopkins did find minor health benefits from low-salt diet, omega-3 fatty acids supplements and possibly folic acid supplements in some people. If aging is the number one cause of suffering, disease and death [2], then it is very likely that future health enthusiasts will turn their energy to longevity compounds as opposed to health products. Fending off biological decay by restoring youthful cell function may become extremely popular targets for tomorrow’s population with the technologies to restore cell function now arriving [3,4].
Existing methods that medical practitioners currently use to prescribe or advise their clients with may also change, with this new paradigm shift away from health products and into maintaining youthful cell function combined with a healthy lifestyle. The human body comprises on average 37x1012 cells, with each cell performing millions of chemical reactions a second [5], and it is the cellular and nuclear machinery that changes over time which causes cells to enter age related dysfunction [6]. Restoring adenosine triphosphate levels [7], methylation markers to previous states [8], preventing telomere attrition [9] and repairing deoxynucleic acid (DNA) [10] are already possible and primary targets in the quest for healthy aging.
Classification systems
Classification systems are found across all facets of industries and life. Systems that classify or scale various classes enable subjects to immediately understand the relative position of something based on the applicable criteria that is known. The longevity industry has now entered a new era, where various longevity technologies are being used by a growing cohort of subjects worldwide. As humanity enters this new era, subjects and their healthcare advisors, even employers such as military or insurance companies may require a classification system to assist in understanding what therapies should be implemented (or avoided) at what time during life. A simplistic classification system with five classes also enables the public to easily see where they sit on a mortality scale and may provide motivation to change their lifestyle. This system is inversely proportional to mortality, the higher your class, the closer you are to death.
With the emerging longevity industry, a surgical difference between health products such as vitamins and minerals and longevity technologies that may restore cell function to more youthful levels has now emerged where health products may become mostly redundant in the quest for longer but not healthier lives [11]. Longevity compounds may begin emerging into the market as consumers start understanding that maintaining youthful cell function is paramount to longevity and age-related disease prevention [12].
In today’s modern world it is extremely rare to find undernourished people in developed nations. This implies that if the diet is balanced, then the evidence suggests that vitamin or mineral supplementation is not required, especially if the goal is for extended life span [13]. Even though this multi-billion-dollar vitamin industry is built on the belief that vitamins and minerals will hopefully ward off disease and death, the evidence does not support this ideology [11,14]. Therefore, longevity compounds and technologies may very well be the future of the health and life extending therapies market. The difference between the two industries brings this discussion to the requirement for a classification system that captures a subject’s position for health and longevity that provides an easy to use and prompt method for understanding one’s own longevity.
This novel classification system does not target specific biomarkers such as blood, microbiome, genetic factors such as telomeric or DNA methylation, and also does not include cancer or other disease screening methodologies. Instead, the system is simply focused on a person’s activity and involvement with emerging or established longevity technologies to simply categorize their prospects for longevity. Even though this classification system may be engineered in future reviews into an extremely detailed and scientific platform, that would be misguided in this instance as the point is to deliver an effortless to follow and use fast classification system that the regular population can understand.
Aging is the number one cause of suffering, disease, and death, so having a system that enables the general public to easily understand and also aim their lifestyle choices with may assist populations in staying healthier, living longer, contributing for longer, and furthermore, saving governments vast amounts of unnecessary health spending [15,2]. Note that our classification system range is from the grossly unhealthy (Type 5) to those that in the future may obtain biological escape velocity (Types 1’s) which simply means staying ahead of biological decay and disease.
Classification system / scale - the intervention on aging
Shown below - Type 5’s (those that are moving through life without any protection to dying) down to Type 1’s (biological escape velocity).
a) Type V – The Type 5 category perform rudimentary functions to maintain life, such as washing hands, using seatbelts in cars, however their diet includes fast food and occasional healthy food, these subjects may hold excessive weight, and overall, they do very little to extend their life or health span. Mortality Risk – Probable.
b) Type IV - The Type 4 demographic exercise and eats relatively healthy and may use health supplements. Type 4’s attempt to navigate away from toxins such as cigarettes, perform weight management, may restrict or abstain from alcohol, though do not implement any emerging or significant longevity technologies or regimes such as fasting or clean plant-based diets. Mortality Risk – Moderate .
c) Type III - The Type 3 class is proactive in using anti-aging technologies, they actively seek and study longevity for increased awareness, they use nicotinamide adenine dinucleotide precursors to maintain cellular metabolism [16], and foods specifically known for their anti-aging properties [17-22], they possibly practice fasting [23-25], use fasting mimetics [26], exercise and are lean or muscular, target a more epigenetic diet19, and steer clear of any biological insults [27]. Mortality Risk – Unlikely .
d) Type II - The Type 2 cohort implements a strict longevity lifestyle which is very similar to Type 3’s, however Type 2’s also implement early disease prevention strategies such as whole genome sequencing, whole exome sequencing, gene panel, single gene testing and methylation analysis to garner data on their disease predisposition and penetrance. Other testing such as glycomic testing [28], blood plasma and proteomic testing [29] and other biomarkers that can assist in predicting and in some cases preventing disease are also used. Mortality Risk – Low.
e) Type I - Type 1’s encompass everything that Type 2’s perform, however Type 1’s have achieved a status of disease prevention and developed strategies to prevent further biological decay through various lifestyle decisions [30], including full spectrum diagnostic services [31-33], gene editing [34] and tissue reprogramming, immune system / thymic rejuvenation [35-37] to ensure .
Even though the technology to deliver Type 1 status remains in its infancy, the technologies discussed here are all under development. If these emerging technologies can enable subjects to achieve Type 1 status, then humanity would have reached what this paper refers to as Biological Escape Velocity, which simply infers that these subjects are able to stay in front of biological decay and disease. Mortality Risk – Extremely Low.
Examples of longevity technologies
Aging could be considered a measured loss of homeostatic mechanisms that augment biological decay in fully developed tissues. Various insults to biological systems such as ultraviolet light, waning coenzymes such as nicotinamide adenine nucleotide (NAD) [38,39] and reduced levels of natural antioxidants such as glutathione [40], super oxide dismutase [41] or diminishing mitochondria levels [42] incapable of powering the cell efficiently and including transmutations of the genome [43] that may ultimately deliver a disease phenotype in later years of human life. Various longevity technologies now exist, such as NAD precursor technologies [44], stem cell replacement therapy 35, mitochondrial boosting technology 45, telomerase induction techniques [46,47], blood dilution [48] and possible organismic-wide rejuvenation through OSK reprogramming [8], as well as various other technologies to stave off the onset of biological decline. These types of well understood technologies are still emerging, though they set the stage for the requirement of a longevity classification system that the public and all healthcare physicians can use as an easy-to-follow system which may assist subjects in changing various lifestyle factors for better health.
Conclusion
Longevity technologies continue to emerge extremely rapidly, and this lays down the requirement for an aging scale that users can aim their biology towards. This allows the general population to easily see and learn what they can do and where they currently sit on the classification system. Our scale clearly demonstrates that there are various stages to longevity management which are completely distinguishable between one another. A classification system such as this also paves the way for governments to set goals and targets for their aging populations. The classification system has been intentionally designed to remain simple and lucid so that all ages and all backgrounds can instantly see where they sit on the classification system and how simple it may be to move onto healthier levels, with the idea being to offer the general population a visual metric to motivate them toward a healthier lifestyle. Even though Type I status is not yet achievable, the scale intentionally includes this category, not only for future use, but as a symbol for humanity’s scientific quest to deliver a disease free and much healthier society. When the general population see that a disease-free phenotype is an achievable goal, we may see more choices that lead them to a longer and healthier life.
Declarations of Interest
Raymond D Palmer is Chief Scientific Officer of Helium 3 Biotech.
References
- Safi UK, Muhammad UK, Haris R, Valavoor S, Zhao Di, et al. (2019) Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map. Ann Intern Med 171(3): 190-198.
- Jaul E, Barron J (2017) Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Front Public Heal 5: 335.
- Rando TA, Chang HY (2012) Aging rejuvenation and epigenetic reprogramming: Resetting the aging clock. Cell 148(1-2): 46-57.
- Weichhart T (2018) mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review. Gerontology 64(2): 127-134.
- Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, et al. (2013) An estimation of the number of cells in the human body. Ann Hum Biol 40(6): 463-471.
- Madreiter-Sokolowski CT, Sokolowski AA, Waldeck-Weiermair M, Malli R, Graier WF (2018) Targeting mitochondria to counteract age-related cellular dysfunction. Genes (Basel) 9(3): 165.
- Verdin E (2015) NAD+ in aging, metabolism, and neurodegeneration. Science 350(6265): 1208-1213.
- Fahy GM, Brooke RT, Watson JP, Good Z, Vasanawala SS, et al. (2019) Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell 18(6): e13028.
- Bekaert S, De Meyer T, Van Oostveldt P (2005) Telomere attrition as ageing biomarker. Anticancer Research 25(4): 3011-3021.
- Murata MM, Kong X, Moncada E, Chen Y, Imamura H, et al. (2019) NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol Biol Cell 30(20): 2584-2597.
- Jenkins DJA, Spence JD, Giovannucci EL, Kim YI, Josse R, et al. (2018) Supplemental Vitamins and Minerals for CVD Prevention and Treatment. J Am Coll Cardiol 71(22): 2570-2584.
- Bonkowski MS, Sinclair DA (2016) Slowing ageing by design: The rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol 17(11): 679-690.
- Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER (2014) Erratum: Stop wasting money on vitamin and mineral supplements. (Annals of Internal Medicine (2013) 159 (850-851). Ann Intern Med 160(2): 143.
- Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ (2005) Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142(1): 37-46.
- Liochev SI (2015) Which Is the Most Significant Cause of Aging? Antioxidants 4(4): 793-810.
- Raymond D. Palmer, Magdy Mahmoud Elnashar, Mauro Vaccarezza (2021) Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging. Aging Med 214-221.
- Park LK, Friso S, Choi SW (2012) Nutritional influences on epigenetics and age-related disease. In: Proceedings of the Nutrition Society. Proc Nutr Soc 71(1): 75-83.
- Link A, Balaguer F, Shen Y, Lozano JJ, Leung HCE, et al. (2013) Curcumin Modulates DNA Methylation in Colorectal Cancer Cells. PLoS One 8(2): e57709.
- Gadecka A, Zmijewska AB (2019) Slowing down ageing: The role of nutrients and microbiota in modulation of the epigenome. Nutrients 11(6): 1251.
- Alegría-Torres JA, Baccarelli A, Bollati V (2011) Epigenetics and lifestyle. Epigenomics 3(3): 267-277.
- Speckmann B, Grune T (2015) Epigenetic effects of selenium and their implications for health. Epigenetics 10(3): 179-190.
- McKay JA, Williams EA, Mathers JC (2004) Folate and DNA methylation during in utero development and aging. In: Biochemical Society Transactions. Biochem Soc Trans 32(pt6): 1006-1007.
- Mattson MP, Longo VD, Harvie M (2017) Impact of intermittent fasting on health and disease processes. Ageing Res Rev 39: 46-58.
- Catterson JH, Khericha M, Dyson MC, Vincent AJ, Callard R, et al. (2018) Short-Term, Intermittent Fasting Induces Long-Lasting Gut Health and TOR-Independent Lifespan Extension. Curr Biol 28(11): 1714.e4-1724.e4.
- Thompson MJ, Chwialkowska K, Rubbi L, Lusis AJ, Davis RC, et al. (2018) A multi-tissue full lifespan epigenetic clock for mice. Aging (Albany NY) 10(10): 2832-2854.
- Cuyas E, Arroyo SF, Buxo M, Pernas S, Dorco J, et al. (2019) Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients. Aging (Albany NY) 11(9): 2874-2888.
- Langie SAS, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, et al. (2015) Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis 36 Suppl 1(Suppl 1): S61-S88.
- Krištić J, Vučković F, Menni C, Klaric L, Keser T, et al. (2014) Glycans are a novel biomarker of chronological and biological ages. Journals Gerontol - Ser A Biol Sci Med Sci 69(7): 779-789.
- Lehallier B, Gate D, Schaum N, Nanasi T, Lee SE, et al. (2019) Undulating changes in human plasma proteome profiles across the lifespan. Nat Med 25(12): 1843-1850.
- Steptoe A, Fancourt D (2019) Leading a meaningful life at older ages and its relationship with social engagement, prosperity, health, biology, and time use. Proc Natl Acad Sci U S A 116(4): 1207-1212.
- Mendelsohn AR, Larrick JW (2017) Epigenetic Drift Is a Determinant of Mammalian Lifespan. Rejuvenation Res 20(5): 430-436.
- Viceconti M, Henney A, Morley-Fletcher E (2016) In silico clinical trials: how computer simulation will transform the biomedical industry. Int J Clin Trials 3(2): 37-46.
- Smith L, Luchini C, Demurtas J, Soysal P, Stubbs B, et al. (2019) Telomere length and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies. Ageing Res Rev 51: 1-10.
- McCormick MA, Delaney JR, Tsuchiya M, Tsuchiyama S, Shemorry A, et al. (2015) A Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene Deletion Strains Uncovers Conserved Mechanisms of Aging. Cell Metab 22(5): 895-906.
- Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10(1): 68.
- Lu Y, Brommer B, Tian X, Krishna A, Meer M, et al. (2020) Reprogramming to recover youthful epigenetic information and restore vision. Nature 588(7836): 124-129.
- Ventevogel MS, Sempowski GD (2013) Thymic Rejuvenation and Aging. Curr Opin Immunol 25(4): 516.
- Braidy N, Berg J, Clement J, Khorshidi F, Poljak A, et al. (2019) Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. Antioxid Redox Signal 30(2): 251-294.
- Schultz MB, Sinclair DA (2016) Why NAD+ Declines during Aging: It’s Destroyed. Cell Metab 23(6): 965-966.
- Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134(3): 489-492.
- Warner HR (1994) Superoxide dismutase, aging, and degenerative disease. Free Radic Biol Med 17(3): 249-258.
- Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29(3-4): 222-230.
- Sun N, Youle RJ, Finkel T (2016) The Mitochondrial Basis of Aging. Mol Cell 61(5): 654-666.
- Rajman L, Chwalek K, Sinclair DA (2018) Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab 27(3): 529-547.
- Katsyuba E, Mottis A, Zietak M, De Franco F, der Velpen VV, et al. (2018) De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature 563(7731): 354-359.
- Saretzki G (2018) Telomeres, Telomerase and Ageing. Subcell Biochem 90: 221-308.
- Corey DR (2009) Telomeres and telomerase: from discovery to clinical trials. Chem Biol 16(12): 1219-1223.
- Melod Mehdipour, Colin Skinner, Nathan Wong, Michael Lieb, Chao Liu, et al. (2020) Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin. Aging 12(10): 8790-8819.